Neurophysiologists play a pivotal role in evaluating how the nervous system functions by decoding its electrical and synaptic signals. Their expertise lies in performing and interpreting tests such as electroencephalography (EEG), electromyography (EMG), and nerve conduction studies to identify dysfunctions in neural transmission. This diagnostic precision enables early detection of conditions like epilepsy, peripheral neuropathies, myopathies, and neuromuscular junction disorders. Neurophysiologists are uniquely positioned at the intersection of clinical care and scientific investigation. Their knowledge directly informs therapeutic strategies, especially in guiding surgical interventions such as cortical mapping prior to tumor resection or epilepsy surgery. In research environments, neurophysiologists help uncover fundamental mechanisms of brain signaling, motor control, and sensory integration. Emerging tools like magnetoencephalography (MEG), transcranial stimulation, and closed-loop neural feedback systems are expanding their scope even further. As artificial intelligence becomes integrated into signal analysis, neurophysiologists now collaborate closely with engineers and data scientists to refine diagnostics. Their contributions extend beyond hospitals and labs into the design of assistive neurotechnologies and rehabilitation protocols. Whether guiding real-time surgical monitoring or exploring the dynamics of consciousness, neurophysiologists provide a foundational understanding of the brain’s functional architecture.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom